<?xml version="1.0" encoding="utf-8"?>
<root>
	<status>success</status>
	<message>The STAT_CONC_DEF field for indicator 3-3-4, translated into en</message>
	<data>&lt;h1&gt;Concepts and definitions&lt;/h1&gt;
&lt;h2&gt;Definition:&lt;/h2&gt;
&lt;p&gt;This indicator is measured indirectly through the proportion of children 5 years of age who have developed chronic HBV infection (i.e. the proportion that tests positive for a marker of infection called hepatitis B surface antigen [HBsAg]).&lt;sup&gt;&lt;a href=&quot;#footnote-1&quot; id=&quot;footnote-ref-1&quot;&gt;[1]&lt;/a&gt;&lt;/sup&gt;&lt;/p&gt;
&lt;p&gt; &lt;/p&gt;
&lt;p&gt;Hepatitis B surface antigen: a protein from the virus&amp;#x2019;s coat. A positive test for HBsAg indicates active HBV infection. The immune response to HBsAg provides the basis for immunity against HBV, and HBsAg is the main component of HepB.&lt;sup&gt;&lt;a href=&quot;#footnote-2&quot; id=&quot;footnote-ref-2&quot;&gt;[2]&lt;/a&gt;&lt;/sup&gt;&lt;/p&gt;
&lt;h2&gt;Concepts:&lt;/h2&gt;&lt;div class=&quot;footnotes&quot;&gt;&lt;div&gt;&lt;sup class=&quot;footnote-number&quot; id=&quot;footnote-1&quot;&gt;1&lt;/sup&gt;&lt;p&gt; Global Hepatitis Report 2017. World Health Organization. ISBN 978-92-4-156545-5. &lt;a href=&quot;#footnote-ref-1&quot;&gt;&amp;#x2191;&lt;/a&gt;&lt;/p&gt;&lt;/div&gt;&lt;div&gt;&lt;sup class=&quot;footnote-number&quot; id=&quot;footnote-2&quot;&gt;2&lt;/sup&gt;&lt;p&gt; Documenting the Impact of Hepatitis B Immunization: best practices for conducting a serosurvey. Immunization, Vaccines and Biologicals. World Health Organization. WHO/IVB/11.08 &lt;a href=&quot;#footnote-ref-2&quot;&gt;&amp;#x2191;&lt;/a&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;</data>
</root>
